-
Innovation Ranking
NewInnovation Ranking – IPG Photonics Corp
IPG Photonics Corp (IPG) is a manufacturer and supplier of fiber lasers and amplifiers. Its product portfolio includes low-power CW fiber lasers, high-power CW fiber lasers, Quasi-CW fiber lasers, mid-IR hybrid lasers, diode laser systems, welding, brazing system, marking, and engraving systems, Raman lasers, telecom amplifiers, chillers, and other components. Its products are used for material processing, laser application centers; telecommunication, medical, advanced, and scientific purposes. IPG offers its products to various industries such as transportation, printing, manufacturing, automotive, medical,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPG-1094 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-1094 in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPG-1094 in Psoriasis Drug Details: IPG-1094 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPG-1094 in Multiple Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-1094 in Multiple Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPG-1094 in Multiple Sclerosis Drug Details: IPG-1094 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPG-1094 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-1094 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPG-1094 in Systemic Lupus Erythematosus Drug Details: IPG-1094 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPG-1094 in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-1094 in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPG-1094 in Multiple Myeloma (Kahler Disease) Drug Details: IPG-1094 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IPG-7236 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-7236 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IPG-7236 in Triple-Negative Breast Cancer (TNBC) Drug Details: IPG-7236 is...
-
Company Insights
Innovation and Patenting activity of IPG Photonics Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of IPG Photonics Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IPG-7236 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IPG-7236 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IPG-7236 in Solid Tumor Drug Details:IPG-7236 is under development for the treatment of...
-
Thematic Analysis
Quantum Computing – Thematic Intelligence
Quantum Computing Theme Analysis Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Empagliflozin + Metformin) in Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Empagliflozin + Metformin) in Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Empagliflozin + Metformin) in Diabetes Drug Details: The fixed dose...